Updated July 13, 2012
By FRANK VINLUAN, special to WRAL Tech Wire
Raleigh firm seeking 'female Viagra' raises $20 million
Post a comment
Print this storyE-mail story
Share
Raleigh, N.C. —
Nearly 60 individual investors flock to support Sprout Pharmaceuticals, which is working toward FDA approval for a compound developed to treat hypoactive sexual desire disorder. It's a form of female sexual dysfunction that essentially means low sexual desire.Copyright 2013 WRAL Tech Wire. All rights reserved.
Please Log In to add a comment.





